Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Codeine sulfate

Codeine sulfate: 2 brands, 1 generic; first approved Jul 16, 2009; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 1 ANDA application approved.

Brands (NDA)
2
Generics (ANDA)
1
Listed patents
0
Presentations
7

Brand (NDA) products

Originator applications
  • CODEINE SULFATERLD
    NDA 02240220093 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    15MGTABLETORALRxAB
    30MGTABLETORALRxAB
    60MGTABLETORALRxAB
  • CODEINE SULFATE
    NDA 2022452011
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    30MG/5MLSOLUTIONORALDiscontinued

Generic (ANDA) products (1)

Abbreviated applications
  • CODEINE SULFATE
    ANDA 20304620143 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    15MGTABLETORALRxAB
    30MGTABLETORALRxAB
    60MGTABLETORALRxAB

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
First approval
17 yr 4 mo ago
Most recent approval
12 yr 4 mo ago

Approvals span 2009–2014 across 3 FDA applications.

Brand (NDA) 267%
Generic (ANDA) 133%

Codeine sulfate: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.